gms | German Medical Science

69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Mexikanischen und Kolumbianischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

03.06. - 06.06.2018, Münster

Hemorrhage risk management of cavernous malformations

Meeting Abstract

  • Sepide Kashefiolasl - Universitätsklinikum Frankfurt, Neurochirurgie, Frankfurt am Main, Deutschland
  • Markus Bruder - Universitätsklinikum Frankfurt, Neurochirurgie, Frankfurt am Main, Deutschland
  • Nina Brawanski - Universitätsklinikum Frankfurt, Neurochirurgie, Frankfurt am Main, Deutschland
  • Eva Herrmann - Universitätsklinikum Frankfurt, Institut für Biostatistik und Mathematische Modellierung, Frankfurt am Main, Deutschland
  • Volker Seifert - Universitätsklinikum Frankfurt, Neurochirurgie, Frankfurt am Main, Deutschland
  • Stephanie Tritt - Universitätsklinikum Frankfurt, Neuroradiologie, Frankfurt am Main, Deutschland
  • Jürgen Konczalla - Universitätsklinikum Frankfurt, Neurochirurgie, Frankfurt am Main, Deutschland

Deutsche Gesellschaft für Neurochirurgie. 69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Mexikanischen und Kolumbianischen Gesellschaft für Neurochirurgie. Münster, 03.-06.06.2018. Düsseldorf: German Medical Science GMS Publishing House; 2018. DocP214

doi: 10.3205/18dgnc554, urn:nbn:de:0183-18dgnc5547

Veröffentlicht: 18. Juni 2018

© 2018 Kashefiolasl et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objective: Despite of the low annual risk of hemorrhage associated with a cavernous malformation (CM) (0,6% to 1,1% per year), the risk of rehemorrhage rate and severity of neurological deficits is significantly higher. We aimed to evaluate different hemorrhage risk factors, particularly in dependence on location as main focus, to define new treatment guidelines for patients with initial diagnosis of CM.

Methods: We retrospectively reviewed medical records of all CM patients admitted to our institution between 1999 and April 2016. Cavernoma volume, anatomical location, existence of a developmental venous anomaly (DVA), number of cavernomas and patient characteristics (sex, age, hypertension and antithrombotic therapy) were analyzed.

Results: 154 CM patients (212 CM lesions) were included, and 89 ruptured CMs were identified. Young age (<45 years) (p<0,05; OR 2,2), infratentorial location (p<0,01; OR 2,9) and the existence of DVA (p<0,0001; OR 4,7) were associated with significant higher risk for CM rupture in our patient cohort. Calculations based on every single CM lesion detected CM size ≥ 1 cm3 (p<0,01; OR 9,9) additionally as an important factor for increased rate of rupture. A separate analysis of different anatomical locations, supratentorial versus infratentorial, indicated the existence of DVA (p<0,01; OR 4,16) in supratentorial and CM volume (≥1 cm³) (p<0,0001; OR 35) in infratentorial cases as significant independent predictors for hemorrhage. Analyzing every single CM lesion in dependence on different locations confirmed previous results.

Conclusion: This study proposed the idea to evaluate hemorrhage rates according to radiologic morphology depending on location. However, to analyze propriety and possible application of our results in daily clinical management of patients with CM, further research is needed. Nevertheless, above mentioned independent hemorrhage predictors can play a key role in individually decision-making process according a surgical or radiosurgical treatment as well as keeping under clinical and radiological observation.